Advertisement Press Releases Archive - Page 141 of 231 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

Search

  • 02 Jan 2013
    COPA-DATA at the SPS IPC Drives 2012

    COPA-DATA at the SPS IPC Drives 2012

    By admin

    At this year`s SPS IPC Drives 2012, COPA-DATA is presenting the zenon 7 Product Family to a wide audience in Germany. Above all, zenon 7 distinguishes itself through its full Multi-Touch support, many more ergonomic enhancements, tools for efficient working as well as maximum performance and security. Due to the anticipated legal specifications for Energy and Environmental Management Systems, the HMI/SCADA specialist is placing additional focus on the monitoring and management of energy consumption. With zenon, customers can increase their energy efficiency and continually save on costs.

  • 02 Jan 2013
  • 02 Jan 2013
    reMYND’s CRO receives governmental grant for a continued innovation of its offering

    reMYND’s CRO receives governmental grant for a continued innovation of its offering

    By admin

    On its Board Meeting of April 28th 2011, the governmental Agency for Innovation by Science and Technology (IWT) has approved a grant to reMYND’s Contract Research Organization (CRO) for the ‘Evaluation of candidate behavioral and synaptic markers in transgenic Alzheimer mouse models, to assess the feasibility of developing such early onset markers for large scale in vivo testing’, herewith recognizing the deliberated innovation efforts of the CRO.

  • 02 Jan 2013
  • 20 Dec 2012
    Phenomenex Introduces 5-micron Kinetex® Core-Shell Media

    Phenomenex Introduces 5-micron Kinetex® Core-Shell Media

    By admin

    Phenomenex Inc a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the addition of a 5-micron particle to its Kinetex core-shell product line. As the largest diameter particle in the family, Kinetex 5-micron core-shell columns deliver better performance than 3- or 5-micron fully porous offerings, with no increase in backpressure.

  • 20 Dec 2012
  • 19 Dec 2012
    SHL’s 2012 Winter Toy & Book Drive

    SHL’s 2012 Winter Toy & Book Drive

    By admin

    As a continuing effort to give back to society, this year SHL organized a Winter Toy & Book Drive, collecting 2nd hand toys and books donated from employees and giving them to World Vision Taiwan for distribution to those in need.

  • 19 Dec 2012
  • 19 Dec 2012
    Aptalis Pharmaceutical Technologies Announces European Commission Approval for a New Oral Granule Formulation of Viread®

    Aptalis Pharmaceutical Technologies Announces European Commission Approval for a New Oral Granule Formulation of Viread®

    By admin

    Aptalis Pharmaceutical Technologies, formerly Eurand Pharmaceutical Technologies, today announced that the European Commission granted marketing authorization for a new pediatric indication of a new oral granule formulation of Gilead Sciences, Inc.'s Viread® (tenofovir disoproxil fumarate) for HIV-1 infected children aged 2 to less than 6 years, and for HIV-1 infected children above 6 years of age for whom a solid dosage form is not appropriate.

  • 13 Dec 2012
«‹139140141142143›»